Colorectal cancer (CRC) is the second most common cause of cancer-related deaths
worldwide. Survival rates are among the most important factors in quality control and …

The advanced stage at diagnosis of colorectal cancer (CRC) may be related to individual
factors, socioeconomic conditions, and healthcare service availability. The objective of the …

Cancer incidence is relatively low in sub-Saharan Africa (SSA), however, prognosis is
expected to be poor in comparison with high-income countries. Comprehensive evidence is …

Aims Currently, the main problems with chemotherapy are its side effects, toxicity, and drug
resistance. Propolis has biological activities, such as anti-inflammatory and anti-cancer …

Background: Overall survival of advanced colorectal cancer (CRC) patients remains poor,
and gene expression analysis could potentially complement detection of clinically relevant …

Maturity-onset diabetes of the young (MODY) is an uncommon monogenic type of diabetes
mellitus. Detecting genetic variants for MODY is a necessity for precise diagnosis and …

Background Colorectal cancer (CRC) is the third most common cancer in Iran. Inflammation
plays an essential role in develo** CRC. A dietary pattern called the empirical dietary …

Adenoma detection rate (ADR) is an imperative quality measure for colorectal cancer (CRC)
screening. This retrospective observational study aimed to determine the trend of polyp …

Background Rectal cancer (RC) poses a significant global health challenge, causing
substantial morbidity and mortality. This study aims to investigate the survival rates of RC …

Background A multitude of randomized controlled trials (RCTs) conducted in both the initial
and subsequent treatment settings for patients diagnosed with metastatic colorectal cancer …